Tetratherix Limited (ASX:TTX) is expanding beyond its core regenerative medicine portfolio, launching a new precision ...

According to the in-depth study published by MarkNtel Advisors, the Global GLP-1 Receptor Agonist Market is projected to grow at a CAGR ...

While Brighterdaysahead ran an admirable race in defeat behind Lossiemouth in the Champion Hurdle, it probably proved that Cheltenham – and specifically the Old course – does not suit her strengths.

THERE WAS success at the double for Wexford jockeys at Cheltenham last week as Conor Stone-Walsh and J.J. Slevin both rode winners at the prestigious meeting. Stone-Walsh rode his first-ever Festival ...

A Nine-Cask Blend From Memphis That Pushes the Boundaries of What Bourbon Can Be There's a bottle sitting on shelves right now — if you can find it — that took years to build. Not in a marketing sen ...

A breakdown of this year’s Best Picture nominees at the Academy Awards, ranking the strongest films in a highly competitive lineup.

Is Game Pass still worth it? It's an open question; a big price increase and another confusing restructure of the ...

Crookhaven is a highly anticipated drama based on the hit global book series by JJ Arcanjo. The eight-part drama series is ...

This episode of The Vet Blast Podcast reveal how in-home can be a benefit to professionals, clients, and patients. On this ...

Donald Trump is now appealing to his NATO allies, and even China, to assist in reopening the passage through the Strait of ...

NYSE-listed Alto Neuroscience has raised $120 million in a private placement that will be used to advance its recently acquired candidate for treatment-resistant depression (TRD) into a pivotal trials ...